|
[1]
Beers M and Berkow R. The Merck
Manual 17th Ed. Systemic Lupus
Erythematosus: 426-430.
[2] Beers M and
Berkow R. The Merck Manual 17th
Ed. Systemic Lupus Erythematosus:
426-430.
[3] Fitzpatrick, T
et al. Color Atlas and Synopsis of
Clinical Dermatology 3rd Ed. 1997
McGraw Hill New York; pp: 346-349.
[4] Beers M and
Berkow R. The Merck Manual 17th
Ed. Systemic Lupus Erythematosus:
426-430.
[5] Beers M and
Berkow R. The Merck Manual 17th
Ed. Systemic Lupus Erythematosus:
426-430.
[6] Fitzpatrick, T
et al. Color Atlas and Synopsis of
Clinical Dermatology 3rd Ed. 1997
McGraw Hill New York; pp: 346-349.
[7] Fitzpatrick, T
et al. Color Atlas and Synopsis of
Clinical Dermatology 3rd Ed. 1997
McGraw Hill New York; pp: 346-349.
[8] Beers M and
Berkow R. The Merck Manual 17th
Ed. Systemic Lupus Erythematosus:
426-430.
[9] www.lupus.org
November 2004.
[10] Beers M and
Berkow R. The Merck Manual 17th
Ed. Systemic Lupus Erythematosus:
426-430.
[11] Mendlovic S
and Sthoeger ZM. n-3 fatty acids
and the immune system in
autoimmunity. Isr Med Assoc J.
2002 Jan; 4(1): 34-38.
[12] Mohan IK and
Das UN. Oxidant stress,
anti-oxidants, and essential fatty
acids in systemic lupus
erythematosus. Prostaglandins
Leukot Essent Fatty Acids. 1997
Mar; 56(3): 193-198.
[13] Walton AJ et
al. Dietary fish oil and the
severity of symptoms in patients
with systemic lupus erythematosus.
Ann Rheum Dis. 1991 Jul; 50(7):
463-466.
[14] Bae SC, Kim
SJ, Sung MK. Impaired anti-oxidant
status and decreased intake of
anti-oxidants in patients with
systemic lupus erythematosus.
Rheumatol Int. 2002 Nov; 22(6):
238-243.
[15] Serban MG,
Balanescu E, and Nita V. Lipid
peroxidase and erythrocyte redox
system in systemic vasculitides
treated with corticosteroids.
Effect of vitamin E
administration. Rom J Intern Med.
1994 Oct-Dec; 32(4): 283-289.
[16] Huisman AM
et al. Vitamin D levels in women
with systemic lupus erythematosus
and fibromyalgia. J Rheumatol.
2001 Nov; 28(11): 2535-2539.
[17] Muller K et
al. Vitamin D3 metabolism in
patients with rheumatic disease:
low serum levels of 25,
hydroxyvitamin D3 in patients with
systemic lupus erythematosus. Clin
Rheumatol. 1995; 14: 397-400.
[18] Sen D and
Keen RW. Osteoporosis in systemic
lupus erythematosus: prevention
and treatment. Lupus 2001; 10(3):
227-232.
[19] Chang DM,
Lan JL, Lin HY, Luo SF. DHEA
treatment of women with mild to
moderate systemic lupus
erythematosus-a multicenter
randomized double blind placebo
controlled trial. Arthritis Rheum.
2002 Nov; 46(11): 2924-2927.
[20] van
Vollenhoven RF et al. A double
blind placebo controlled clinical
trial of DHEA in severe systemic
lupus erythematosus. Lupus 1999;
8(3): 181-187.
[21] Bae SC, Kim
SJ, Sung MK. Impaired anti-oxidant
status and decreased intake of
anti-oxidants in patients with
systemic lupus erythematosus.
Rheumatol Int. 2002 Nov; 22(6):
238-243.
[22]
Vien CV et al. Effect of vitamin A
treatment on the immune reactivity
of patients with systemic lupus
erythematosus. J Clin Lab Immunol.
1988; 26: 33-35.
Return to Lupus Introduction |